Viking Global Investors’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,337,854
| Closed | -$63M | – | 94 |
|
|
2022
Q2 | $63M | Buy |
2,337,854
+491,207
| +27% | +$13.2M | 0.29% | 62 |
|
|
2022
Q1 | $62.9M | Buy |
1,846,647
+1,088,766
| +144% | +$37.1M | 0.25% | 71 |
|
|
2021
Q4 | $29.3M | Sell |
757,881
-4,415
| -0.6% | -$171K | 0.08% | 100 |
|
|
2021
Q3 | $41.2M | Buy |
+762,296
| New | +$41.2M | 0.11% | 87 |
|
|
2013
Q4 | – | Sell |
-44,834
| Closed | -$23.8M | – | 68 |
|
|
2013
Q3 | $23.8M | Buy |
+44,834
| New | +$23.8M | 0.13% | 55 |
|